Skip to main content

Table 2 S100A2 expression associated with clinicopathologic characteristics (logistic regression)

From: High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma

Characteristics Total(N) Odds Ratio(OR) P value
Clinical stage (Stage IV&Stage III vs. Stage I&Stage II) 552 1.505 (1.039-2.186) 0.031
Primary therapy outcome (PD&SD&PR vs. CR) 480 0.973 (0.499-1.897) 0.936
Weight (>80 vs. <=80) 528 1.079 (0.766-1.520) 0.662
Age (>60 vs. <=60) 549 0.934 (0.661-1.320) 0.700
BMI (>30 vs. <=30) 519 1.266 (0.892-1.800) 0.187
Histological type (Serous&Mix vs. Endometrioid) 552 1.778 (1.209-2.632) 0.004
Histologic grade (G3 vs. G1&G2) 541 1.173 (0.832-1.656) 0.362
Residual tumor (R1&R2 vs. R0) 413 1.007 (0.512-1.967) 0.984
Tumor invasion(%) (>=50 vs. <50) 474 1.188 (0.827-1.707) 0.352
Menopause status (Peri&Post vs. Pre) 506 2.078 (1.028-4.408) 0.047
Diabetes (Yes vs. No) 451 0.725 (0.477-1.098) 0.129